Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common stock, $0.001 par value per share
-
Shares outstanding
-
12,986,368
-
Total 13F shares
-
11,555,279
-
Share change
-
+74,675
-
Total reported value
-
$337,769,826
-
Put/Call ratio
-
0.83%
-
Price per share
-
$29.23
-
Number of holders
-
151
-
Value change
-
+$2,942,831
-
Number of buys
-
79
-
Number of sells
-
61
Institutional Holders of EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) as of Q4 2022
As of 31 Dec 2022,
EAGLE PHARMACEUTICALS, INC. - Common stock, $0.001 par value per share (EGRX) was held by
151 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,555,279 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, STATE STREET CORP, VANGUARD GROUP INC, BRANDES INVESTMENT PARTNERS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
151
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.